This is a prospective study that aimed to observe the therapeutic effects of minor salivary gland transplantation for cicatrizing conjunctivitis patients.
Age range
20 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
the change of Schirmer's test result (basic tear secretion in mm) from baseline to 12 months after operation
Timeframe: the Schirmer's test will be performed every three months until 12 months after operation
the change of ocular surface disease index (OSDI) ( ranged from 0-100) from baseline to 12 months after operation
Timeframe: the OSDI will be monitored every three months until 12 months
the change of chronic ocular complication score (COCS) ( ranged from 0-12) from baseline to 12 months after operation
Timeframe: the COCS will be monitored every three months until 12 months after operation